Bristol Myers Squibb (BMY)

SG&A Expenses

$7.41B

TTM · Period ending: · USD

BMY logo

BMY SG&A Expenses

Latest reported$7.41B
BMY SG&A Expenses ($3.79B → $7.41B)
High-resolution chart · PNG

BMY sg&a expenses history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Bristol Myers Squibb SG&A Expenses — Annual fiscal periods (USD)
Period endingSG&A Expenses (USD)
7,267,000,000
8,414,000,000
7,772,000,000
7,814,000,000
7,690,000,000
7,661,000,000
4,871,000,000
4,551,000,000
4,751,000,000
4,979,000,000
5,001,000,000
5,699,000,000
5,104,000,000
5,175,000,000
5,170,000,000
4,691,000,000
5,214,000,000
5,354,000,000
6,320,000,000
6,140,000,000
6,453,000,000
6,427,000,000
6,035,000,000
5,267,000,000
5,193,000,000
5,532,000,000
5,338,000,000
5,203,000,000
6,414,000,000
5,871,000,000
5,316,000,000
4,533,000,000
5,981,000,000
6,339,000,000
5,463,000,000
5,037,000,000
5,450,000,000
4,304,000,000
3,789,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.